These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18349037)

  • 1. Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit.
    Sweeting MJ; De Angelis D; Hickman M; Ades AE
    Biostatistics; 2008 Oct; 9(4):715-34. PubMed ID: 18349037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C infection among injecting drug users in England and Wales (1992-2006): there and back again?
    Sweeting MJ; Hope VD; Hickman M; Parry JV; Ncube F; Ramsay ME; De Angelis D
    Am J Epidemiol; 2009 Aug; 170(3):352-60. PubMed ID: 19546152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the prevalence of ex-injecting drug use in the population.
    Sweeting M; De Angelis D; Ades A; Hickman M
    Stat Methods Med Res; 2009 Aug; 18(4):381-95. PubMed ID: 19036912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?
    Hope VD; Judd A; Hickman M; Lamagni T; Hunter G; Stimson GV; Jones S; Donovan L; Parry JV; Gill ON
    Am J Public Health; 2001 Jan; 91(1):38-42. PubMed ID: 11189821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Bayesian evidence synthesis approach to estimate disease prevalence in hard-to-reach populations: hepatitis C in New York City.
    Tan S; Makela S; Heller D; Konty K; Balter S; Zheng T; Stark JH
    Epidemics; 2018 Jun; 23():96-109. PubMed ID: 29666018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales.
    De Angelis D; Sweeting M; Ades A; Hickman M; Hope V; Ramsay M
    Stat Methods Med Res; 2009 Aug; 18(4):361-79. PubMed ID: 19036917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of hepatitis C in England and Wales.
    Balogun MA; Ramsay ME; Hesketh LM; Andrews N; Osborne KP; Gay NJ; Morgan-Capner P
    J Infect; 2002 Nov; 45(4):219-26. PubMed ID: 12423608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil.
    Silva MB; Andrade TM; Silva LK; Rodart IF; Lopes GB; Carmo TM; Zarife MA; Dourado I; Reis MG
    Mem Inst Oswaldo Cruz; 2010 May; 105(3):299-303. PubMed ID: 20512243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male IDUs who have sex with men in England, Wales and Northern Ireland: are they at greater risk of bloodborne virus infection and harm than those who only have sex with women?
    Marongiu A; Hope VD; Parry JV; Ncube F
    Sex Transm Infect; 2012 Oct; 88(6):456-61. PubMed ID: 22628667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis.
    Harris RJ; Ramsay M; Hope VD; Brant L; Hickman M; Foster GR; De Angelis D
    Eur J Public Health; 2012 Apr; 22(2):187-92. PubMed ID: 21708792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
    van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J
    Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection.
    Balogun MA; Ramsay ME; Parry JV; Donovan L; Andrews NJ; Newham JA; McGarrigle C; Harris KA; Teo CG
    Sex Transm Infect; 2003 Aug; 79(4):301-6. PubMed ID: 12902580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B and hepatitis C seroprevalence and risk behaviour among community-recruited drug injectors in North West Wales.
    Craine N; Walker AM; Williamson S; Brown A; Hope VD
    Commun Dis Public Health; 2004 Sep; 7(3):216-9. PubMed ID: 15481216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
    Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.
    Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M
    Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection among a cohort of Victorian injecting drug users.
    Crofts N; Hopper JL; Bowden DS; Breschkin AM; Milner R; Locarnini SA
    Med J Aust; 1993 Aug; 159(4):237-41. PubMed ID: 7692222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland.
    Hutchinson SJ; Bird SM; Goldberg DJ
    Hepatology; 2005 Sep; 42(3):711-23. PubMed ID: 16116637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.